说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 词典 -> 千解草甲素
1)  pygmaeocine A
千解草甲素
2)  oroxylin-A
千层纸甲素A
1.
Determination of oroxylin-A in Angongning capsules by TLC-scanning;
薄层扫描法测定安宫宁胶囊中千层纸甲素A的含量
3)  Bulleyaconitine A
草乌甲素
1.
Preparation of Bulleyaconitine A microemulsion and investigation of its physicochemical properties;
草乌甲素微乳的制备及其理化性质的考察
2.
Inhibitory effect of bulleyaconitine A on some immune function in Balb/c mice;
草乌甲素对Balb/c小鼠的部分免疫功能的抑制作用
3.
Determination of entrapment efficiency of bulleyaconitine A multivesicular liposomes;
草乌甲素多囊脂质体包封率的测定
4)  Oridonin
冬凌草甲素
1.
Orthogonal Experimental Research on Decoction Technology of Oridonin;
冬凌草甲素提取工艺的正交实验研究
2.
Determination of Oridonin in Rabdosia Rubescens tea by Reversed Phase High Performance Liquid Chromatography;
反相高效液相色谱法测定冬凌草茶中的冬凌草甲素
3.
New method for preparing oridonin by supercritical CO_2 fluid extraction and column chromatography;
超临界CO_2萃取-柱色谱分离联用制备冬凌草甲素新工艺的研究
5)  rubescensine A
冬凌草甲素
1.
Study on the quantum chemical calculations is performed by means of MNDO method on VAX8350 computer for rubescensine A and its acetylate derivative.
本文用MNDO方法在VAX8350计算机上对冬凌草甲素及其乙酰衍生物进行了量子化学计算研究。
2.
Objective: To investigate the mechanism of GBC-SD(gallbladder cell-Shandong) apoptosis induced by Rubescensine A.
目的:探讨冬凌草甲素(RuA)对人胆囊癌细胞株(GBC-SD)诱导凋亡的机制。
3.
One of its main components, Rubescensine A, was extracted and expected to become a new Class I drug in Wuhan Botanical Garden, the Chinese Academy of Sciences.
中国科学院武汉植物园从冬凌草药材中提取出冬凌草甲素,制成了抗癌一类新药RAC。
6)  5,8-dihydroxy-2-(1-methoxy-4-methyl-3-pentenyl)-1,4-naphthalenedione
甲基紫草素
1.
The IC50values of deoxyshikonin(Ⅰ),β,β-dimethylacrylshikonin(Ⅱ),isobutylshikonin(Ⅲ),shikonin(Ⅳ),5,8-dihydroxy-2-(1-methoxy-4-methyl-3-pentenyl)-1,4-naphthalenedione(Ⅴ),β-sitosterol(Ⅵ),.
去氧紫草素(Ⅰ)、β,β-二甲基丙烯酰紫草素(Ⅱ)、异丁酰紫草素(Ⅲ)、紫草素(Ⅳ)、甲基紫草素(Ⅴ)、β-谷甾醇(Ⅵ)、咖啡酸脂肪醇酯混合物(Ⅶ)和DDP对胃癌细胞MGC-803的IC50分别为:1。
补充资料:促甲状腺素释放激素、促甲释放素
分子式:
CAS号:

性质:又称促甲状腺素释放激素、促甲释放素。为简单的三肽。易溶于无水甲醇,略溶于氯仿,不溶于吡啶。为下丘脑分泌的多肽激素。促进垂体生成促甲状腺素,同时还能刺激垂体释放泌乳素。可影响细胞钙库,增加Ca2+浓度而发挥作用;且有抗内毒素性休克作用。用于诊断甲状腺功能,判定甲状腺功能亢进复发趋势。也可治疗甲状腺机能减退和甲状腺癌患者。制剂为注射剂。

说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条